ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) characterized by absent or minimal expression of oestrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) is a highly heterogeneous and aggressive disease and has the worst prognosis among the different subtypes of breast cancer [1, 2].